We are live on
!
Find out more
Iovance Biotherapeutics
IOVA
IOVA
153 hedge funds and large institutions have $1.12B invested in Iovance Biotherapeutics in 2019 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 36 increasing their positions, 49 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
461% more call options, than puts
Call options by funds: $1.33M | Put options by funds: $238K
94% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 17
10% more funds holding
Funds holding: 139 → 153 (+14)
6% more capital invested
Capital invested by funds: $1.05B → $1.12B (+$67.2M)
1.19% less ownership
Funds ownership: 96.25% → 95.06% (-1.2%)
13% less funds holding in top 10
Funds holding in top 10: 8 → 7 (-1)
27% less repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 49
Holders
153
Holders Change
+14
Holders Change %
+10.07%
% of All Funds
3.31%
Holding in Top 10
7
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-12.5%
% of All Funds
0.15%
New
33
Increased
36
Reduced
49
Closed
17
Calls
$1.33M
Puts
$238K
Net Calls
+$1.1M
Net Calls Change
+$128K
Top Buyers
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$24.2M |
| 2 |
BC
Broadfin Capital
New York
|
-$15.8M |
| 3 |
SSA
Schonfeld Strategic Advisors
New York
|
-$7.28M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$5.32M |
| 5 |
State Street
Boston,
Massachusetts
|
-$4.04M |
